Updated August 2026
Cinnamon & Berberine: What The Research Actually Shows
Cinnamon has genuine human research behind it at specific doses, mostly in people with diagnosed diabetes. Berberine is widely discussed in the same category, but neither ingredient’s research tells you what a GlycoMode serving specifically contains.
What the cinnamon research actually found
A 2015 review by Kawatra and Rajagopalan, published in Pharmacognosy Research, summarized a meta-analysis of ten randomized controlled trials across 543 patients. Cinnamon doses between 120 milligrams and 6 grams per day, taken for roughly four months, were associated with a measurable decrease in fasting plasma glucose along with improved lipid measures. The same review also noted conflicting or non-significant results in some individual trials, and called for further research.
Why dose range matters here
That 120mg-to-6g range is enormous — a fifty-fold difference between the low and high end. Without knowing where in that range (or below it) a specific product’s cinnamon content falls, citing the research doesn’t tell you much about what you’re actually taking.
Where Berberine fits
Berberine is a compound found in several plants and is commonly discussed in both glucose and cholesterol research. It shows up twice in GlycoMode’s ingredient framing — once for blood sugar, once for cholesterol — which is a reasonable use of a single ingredient with research relevant to both areas, though again without disclosed dosing.